No black box warning on record for Aztreonam

As of the latest FDA labeling reviewed, Aztreonam (AZTREONAM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Aztreonam medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Both animal and human data suggest that aztreonam for injection, USP is rarely cross-reactive with other beta-lactam antibiotics and weakly immunogenic. Treatment with aztreonam can result in hypersensitivity reactions in patients with or without prior exposure. (See CONTRAINDICATIONS . ) Careful inquiry should be made to determine whether the patient has any history of hypersensitivity r

No black box warning on record for Aztreonam

Other warnings & precautions

WARNINGS Both animal and human data suggest that aztreonam for injection, USP is rarely cross-reactive with other beta-lactam antibiotics and weakly immunogenic. Treatment with aztreonam can result in hypersensitivity reactions in patients with or without prior exposure. (See CONTRAINDICATIONS . ) Careful inquiry should be made to determine whether the patient has any history of hypersensitivity r

Aztreonam Black Box Warning

No black box warning on record for Aztreonam

Other warnings & precautions

Aztreonam Black Box Warning

No black box warning on record for Aztreonam

Other warnings & precautions